Navigation Links
Johnson Controls Secures Global Facilities Management Win With GlaxoSmithKline

MILWAUKEE, May 5 /PRNewswire/ -- Johnson Controls (NYSE: JCI) Global WorkPlace Solutions today announced it has won a global contract to provide workplace services to pharmaceutical and healthcare company GlaxoSmithKline (GSK).

The five-year contract builds on an 18-year relationship Johnson Controls has had with GSK as a facility services provider. It will initially cover GSK sites across North and South America, Europe and China – with other sites being brought on in a managed process as they are ready. Johnson Controls will provide GSK with workplace services including technical and engineering services, energy management, project management and pharmaceutical services, for the company's research and development, manufacturing and corporate offices.

With headquarters in the United Kingdom and with operations based around the world, GSK is a market leader in the pharmaceutical and healthcare industry.  Through this contract Johnson Controls is helping GSK achieve its strategic priority of "simplifying the operating model" by delivering services that are responsive to changes in GSK's business model.

Guy Holden, vice president & general manager, Global WorkPlace Solutions, said, "Johnson Controls has had the privilege of providing GSK with facilities services for the last 18 years. This major new contract win represents an exciting expansion of our relationship and the opportunity to deliver workplace services that make a direct and meaningful contribution to GSK's business.

"One of the main reasons we were selected was because of our proven track record in the pharmaceutical and healthcare industry internationally, and in delivering transformational change in highly regulated life science environments," Holden added.

John Summers, vice president and general manager of Life Sciences, Global WorkPlace Solutions commented: "We are extremely pleased to be partnering with GSK to deliver workplace services for the company globally.

"The contract creates further expansion of our footprint in the United Kingdom and in the United States and expands our current operations in emerging markets such as Brazil and China. As GSK continues to develop the global services model into other business units and geographies our opportunities for continued growth are significant," Summers added.

Johnson Controls Global WorkPlace Solutions will start delivering services under the new contract beginning in summer 2010.

Johnson Controls Global WorkPlace Solutions is the world's largest global real estate and facilities management business offering a single-source for real estate portfolio management, design and project management, integrated technologies, strategic consulting, and energy and facilities management services. The business unit has more than 17,000 employees working with clients across 75 countries, serving real estate portfolios and managing facilities totaling approximately 1.5 billion square feet.

About Johnson Controls

Johnson Controls is a global diversified technology and industrial leader serving customers in over 150 countries. Our 130,000 employees create quality products, services and solutions to optimize energy and operational efficiencies of buildings; lead-acid automotive batteries and advanced batteries for hybrid and electric vehicles; and interior systems for automobiles. Our commitment to sustainability dates back to our roots in 1885, with the invention of the first electric room thermostat. Through our growth strategies and by increasing market share we are committed to delivering value to shareholders and making our customers successful.

About Johnson Controls Building Efficiency

Johnson Controls Building Efficiency is a leading provider of equipment, controls and services for heating, ventilating, air-conditioning, refrigeration and security systems for buildings. Operating from 500 branch offices in 150 countries, we deliver products, services and solutions that increase energy efficiency and lower operating costs for over one million customers. We are involved in more than 500 renewable energy projects including solar, wind and geothermal technologies. Our solutions have reduced carbon dioxide emissions by 13.6 million metric tons and generated savings of $7.5 billion since 2000. Many of the world's largest companies rely on us to manage 1.5 billion square feet of their commercial real estate.

SOURCE Johnson Controls
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
2. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
3. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
4. Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
5. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
6. Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
7. U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nations Largest Nursing Home Pharmacy
8. EF Johnson Technologies Announces Third Quarter Results
9. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
10. Johnson & Johnson to Participate in the 30th Annual Cowen and Company Health Care Conference
11. Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Therapeutic Drug Monitoring (TDM) ... Competitive Intelligence, Emerging Opportunities"  report to ... ) has announced the addition of ...
(Date:11/26/2015)... ) has announced ... High Viscosity Drugs" report to their offering. ... addition of the "Self Administration of High ... --> Research and Markets ( ) ... Administration of High Viscosity Drugs" report to ...
(Date:11/26/2015)... , November 26, 2015 ... addition of the "Radioimmunoassay Market by ... (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), ... Global Forecast to 2020" report to ... has announced the addition of the ...
Breaking Medicine Technology:
(Date:11/28/2015)... , ... November 28, 2015 , ... Trying to relax ... created the COUCH BUDDY. "I conceived of this design due to personal experience with ... couch users. It promotes relaxation and convenience, as well as increases support. It also ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published ... Association meeting in Washington D.C. revolved around the fact that proper dental care, both ... talk stressed the link between periodontal disease (more commonly referred to as gum disease) ...
(Date:11/27/2015)... Raleigh, NC (PRWEB) , ... November 27, 2015 , ... ... most effective ways to treat it. Surviving Mesothelioma has just posted the findings ... Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print ... USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation ... is distributed nationally, through a vast social media strategy and across a network ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec ... Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users ... Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status ...
Breaking Medicine News(10 mins):